Geneva Advisors’s Aemetis AMTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$2.08M Buy
1,562,431
+50,800
+3% +$67.6K 0.04% 211
2017
Q1
$1.95M Buy
1,511,631
+32,400
+2% +$45K 0.03% 214
2016
Q4
$2.06M Buy
1,479,231
+26,100
+2% +$42.5K 0.04% 202
2016
Q3
$1.57M Buy
1,453,131
+68,460
+5% +$115K 0.03% 239
2016
Q2
$3.16M Buy
1,384,671
+68,100
+5% +$168K 0.06% 149
2016
Q1
$2.69M Buy
1,316,571
+52,175
+4% +$103K 0.05% 151
2015
Q4
$3.67M Buy
1,264,396
+135,666
+12% +$335K 0.07% 130
2015
Q3
$3.1M Buy
1,128,730
+201,625
+22% +$657K 0.06% 149
2015
Q2
$3.34M Buy
927,105
+84,937
+10% +$371K 0.06% 157
2015
Q1
$3.55M Buy
842,168
+104,708
+14% +$454K 0.06% 155
2014
Q4
$4.27M Buy
737,460
+261,127
+55% +$1.72M 0.08% 138
2014
Q3
$4.13M Buy
476,333
+53,677
+13% +$528K 0.08% 141
2014
Q2
$4.03M Buy
+422,656
New +$3.72M 0.07% 147

Other funds holding AMTX

Geneva Advisors's AMTX Position: Q2 2017 in Review

Geneva Advisors increased its Aemetis (AMTX) stake by 3.4% in Q2 2017, buying an estimated $67.6K and bringing the position to 1,562,431 shares worth $2.08M. The position accounts for 0.04% of the portfolio, ranked #211.

Geneva Advisors first reported a position in AMTX in Q2 2014 and has held it in 13 quarters since. The position peaked at $4.27M in Q4 2014. 21 funds tracked by Wall St. Rank hold AMTX as of Q2 2017.

  • Geneva Advisors held 1,562,431 shares of Aemetis worth $2.08M as of Q2 2017.
  • Geneva Advisors bought 50,800 Aemetis shares in Q2 2017, an estimated $67.6K.
  • Aemetis made up 0.04% of Geneva Advisors's portfolio in Q2 2017, its #211 holding.
  • Geneva Advisors first reported a position in Aemetis in Q2 2014 and has held it in 13 quarters since.
  • Geneva Advisors's Aemetis position peaked at $4.27M in Q4 2014.
  • 21 funds tracked by Wall St. Rank held Aemetis as of Q2 2017.

Based on Geneva Advisors's 13F filing for Q2 2017, filed 7 Aug 2017.